Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Acquisition/DispositionItem 2.01 · 8-KLOW RiskNeutral

Cytosorbents Corporation

Filed: Mar 25, 2026CIK: 0001175151Health Care
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Cytosorbents Corporation released its financial results for the quarter and year ended December 31, 2025 on March 25, 2026. This routine earnings announcement fulfills SEC reporting obligations and provides investors with transparency on the company's financial performance and operational achievements.

Key Takeaways

Company completed its annual and quarterly financial reporting for fiscal year 2025

Results were disseminated via press release as part of standard investor communication strategy

2 more takeaways

Related Filings (1)

1 more filing from Cytosorbents Corporation in the last 90 days

Filing Overview

Form Type8-K
Filing DateMar 25, 2026
Item2.01
CategoryAcquisition/Disposition
CIK0001175151
Accession #0001175151
Risk LevelLOW
SentimentNeutral
Signalinformational
Topics
earnings

What This Means

The company completed a major acquisition or sold off a significant asset. This reshapes the company's portfolio and strategic direction.
View Full Filing on SEC.govBrowse More Filings